GSK3B and Alzheimer disease: ATP‐competitive inhibitors indirubin, hymenialdisin, and SB216763 can inhibit GSK‐3β enzyme activity, alleviate Aβ deposition and tau hyperphosphorylation‐associated neuropathological changes, and improve cognitive impairment in AD animal models.113, 114